Cancer Epigenetics & Methyl-CpG (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. Here is the latest research on cancer epigenetics and methyl-CpG binding proteins including ZBTB38.

February 24, 2021

Depletion of H3K36me2 recapitulates epigenomic and phenotypic changes induced by the H3.3K36M oncohistone mutation.

Proceedings of the National Academy of Sciences of the United States of America
Kartik N RajagopalanChao Lu
February 24, 2021

Integrative analysis of genome-wide DNA methylation and gene expression profiles reveals important epigenetic genes related to milk production traits in dairy cattle.

Journal of Animal Breeding and Genetics = Zeitschrift Für Tierzüchtung Und Züchtungsbiologie
Wanting DongLi Jiang
February 24, 2021

Impact of RASSF1A gene methylation on clinico-pathological features of tumor and non-tumor tissue of breast cancer.

Annals of Diagnostic Pathology
Vivek GuptaPrajakta Deshpande
February 20, 2021
Open Access

Global transcriptome profile of the developmental principles of in vitro iPSC-to-motor neuron differentiation.

BMC Molecular and Cell Biology
Emilia SolomonRashi Iyer
February 20, 2021
Review

Comprehensive analysis of regulation of DNA methyltransferase isoforms in human breast tumors.

Journal of Cancer Research and Clinical Oncology
Mangala Hegde, Manjunath B Joshi
February 20, 2021

The growing landscape of succinylation links metabolism and heart disease.

Epigenomics
Lanting YangJianxun Wang
February 20, 2021

Molecular and epigenetic modes of Fumonisin B1 mediated toxicity and carcinogenesis and detoxification strategies.

Critical Reviews in Toxicology
Thilona ArumugamAnil A Chuturgoon
February 20, 2021
Review

DLX6-AS1 is a potential biomarker and therapeutic target in cancer initiation and progression.

Clinica Chimica Acta; International Journal of Clinical Chemistry
Qiuxian ZhengZhi Chen
February 20, 2021
Review

miRNAs: Critical mediators of breast cancer metastatic programming.

Experimental Cell Research
Madhumathy G NairT S Sridhar
February 19, 2021
Review
Open Access

Methyladenosine Modification in RNAs: Classification and Roles in Gastrointestinal Cancers.

Frontiers in Oncology
Qinghai LiGuohui Wan
February 19, 2021
Review
Open Access

Review on circular RNAs and new insights into their roles in cancer.

Computational and Structural Biotechnology Journal
Xiaozhu TangChunyan Gu
February 18, 2021

Differentially methylated regions within lung cancer risk loci are enriched in deregulated enhancers.

Epigenetics : Official Journal of the DNA Methylation Society
Marina LaplanaAngela Risch
February 17, 2021

Nuclear long non-coding RNAs as epigenetic regulators in cancer.

Current Medicinal Chemistry
Hiroaki Tachiwana, Noriko Saitoh
February 16, 2021
Open Access

Searching for a Putative Mechanism of RIZ2 Tumor-Promoting Function in Cancer Models.

Frontiers in Oncology
Monica RienzoCiro Abbondanza
February 16, 2021

EBV as a high infection risk factor promotes RASSF10 methylation and induces cell proliferation in EBV-associated gastric cancer.

Biochemical and Biophysical Research Communications
Yingxue GaoJian Ma

Sign up to follow this feed and discover related papers.

Related Feeds

Aging Genetics (Keystone)

This feed focuses on aging epidemiology and genetic, epigenetic, and proteomic aspects underlying aging, as well as aging- associated biomarkers. Here the latest research in this domain.

Anthracycline Sensitivity & Chromatin (Keystone)

Anthracyclines are used in the treatment of cancer and work by inhibiting topoisomerase II (TOP2). Recent evidence suggests that because DNA accessibility is crucial for TOP2 binding, chromatin regulatory genes should predict anthracycline response. Find the latest research on anthracycline sensitivity and chromatin regulators in this feed.

B-Cell Leukemia (Keystone)

B-cell leukemia includes various types of lymphoid leukemia that affect B cells. Here is the latest research on B-cell leukemia.

Breast Invasive Carcinoma (Keystone)

Invasive breast cancers indicate a spread into breast tissues and lymph nodes. Here are the latest discoveries pertaining to breast invasive carcinomas.

Cancer Epigenetics & Metabolism (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. This feed focuses on the relationship between cell metabolism, epigenetics and tumor differentiation.

Cancer Epigenetics (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. Here is the latest research on cancer epigenetics.

Cancer Epigenetics Chromatin Complexes (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. This feed focuses on chromatin complexes and their role in cancer epigenetics.

Cancer Epigenetics and Chemical Tools (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. Using novel chemical tools allows us to learn more about these epigenetic changes and how they impact the neoplastic process. Follow this feed to learn more about cancer epigenetics and chemical tools.

Cancer Epigenetics and Chromatin (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. This feed focuses on chromatin and its role in cancer epigenetics please follow this feed to learn more.

Cancer Epigenetics and Senescence (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may be involved in regulating senescence in cancer cells. This feed captures the latest research on cancer epigenetics and senescence.

© 2021 Meta ULC. All rights reserved
/feed-previews/cancer-epigenetics-methyl-cpg/f3c91744-dbe8-47de-9ee6-0543e8abbe4a